Sumitomo Mitsui Trust Holdings, Inc. Veracyte, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$156 Billion
Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,647,177 shares of VCYT stock, worth $58.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,647,177

Previous 2,263,939 27.24%

Holding current value

$58.7 Million

Previous $67.1 Million 33.67%

% of portfolio

0.03%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$26.39 - $32.62 $16.3 Million - $20.1 Million	-616,762 Reduced 27.24%	1,647,177 $44.5 Million
Q1 2025 Apr 25, 2025	SELL	$29.65 - $46.14 $6.8 Million - $10.6 Million	-229,438 Reduced 9.2%	2,263,939 $67.1 Million
Q4 2024 Jan 28, 2025	SELL	$31.92 - $44.4 $8.27 Million - $11.5 Million	-259,006 Reduced 9.41%	2,493,377 $98.7 Million
Q3 2024 Nov 05, 2024	SELL	$21.0 - $35.25 $9.01 Million - $15.1 Million	-429,209 Reduced 13.49%	2,752,383 $93.7 Million
Q2 2024 Jul 19, 2024	SELL	$18.86 - $23.55 $3.13 Million - $3.91 Million	-165,844 Reduced 4.95%	3,181,592 $68.9 Million
Q1 2024 Apr 19, 2024	BUY	$21.0 - $29.1 $5.1 Million - $7.06 Million	242,760 Added 7.82%	3,347,436 $74.2 Million
Q4 2023 Jan 30, 2024	SELL	$19.72 - $28.68 $1.36 Million - $1.98 Million	-68,900 Reduced 2.17%	3,104,676 $85.4 Million
Q3 2023 Oct 30, 2023	SELL	$22.33 - $29.92 $1.68 Million - $2.26 Million	-75,437 Reduced 2.32%	3,173,576 $70.9 Million
Q2 2023 Jul 31, 2023	SELL	$20.96 - $26.99 $966,318 - $1.24 Million	-46,103 Reduced 1.4%	3,249,013 $82.8 Million
Q1 2023 Apr 27, 2023	BUY	$20.58 - $27.89 $4.75 Million - $6.43 Million	230,671 Added 7.53%	3,295,116 $73.5 Million
Q4 2022 Jan 30, 2023	BUY	$15.31 - $29.94 $926,668 - $1.81 Million	60,527 Added 2.01%	3,064,445 $72.7 Million
Q3 2022 Oct 21, 2022	BUY	$16.58 - $27.9 $1.37 Million - $2.3 Million	82,440 Added 2.82%	3,003,918 $49.9 Million
Q2 2022 Jul 26, 2022	SELL	$15.45 - $29.52 $1.45 Million - $2.76 Million	-93,563 Reduced 3.1%	2,921,478 $58.1 Million
Q1 2022 Apr 27, 2022	SELL	$21.94 - $42.51 $2.33 Million - $4.51 Million	-106,062 Reduced 3.4%	3,015,041 $83.1 Million
Q4 2021 Feb 02, 2022	BUY	$36.09 - $53.79 $5.94 Million - $8.86 Million	164,724 Added 5.57%	3,121,103 $129 Million
Q3 2021 Oct 25, 2021	SELL	$35.62 - $52.97 $7.55 Million - $11.2 Million	-211,859 Reduced 6.69%	2,956,379 $137 Million
Q2 2021 Aug 02, 2021	SELL	$32.94 - $56.62 $3.01 Million - $5.17 Million	-91,284 Reduced 2.8%	3,168,238 $127 Million
Q1 2021 Apr 30, 2021	SELL	$44.47 - $81.38 $556,586 - $1.02 Million	-12,516 Reduced 0.38%	3,259,522 $175 Million
Q4 2020 Feb 05, 2021	BUY	$32.49 - $61.88 $9.38 Million - $17.9 Million	288,583 Added 9.67%	3,272,038 $160 Million
Q3 2020 Oct 30, 2020	SELL	$26.73 - $35.67 $4.32 Million - $5.77 Million	-161,731 Reduced 5.14%	2,983,455 $96.9 Million
Q2 2020 Jul 27, 2020	SELL	$19.49 - $28.11 $2.77 Million - $4 Million	-142,281 Reduced 4.33%	3,145,186 $81.5 Million
Q1 2020 Apr 27, 2020	BUY	$16.13 - $30.17 $3.78 Million - $7.07 Million	234,216 Added 7.67%	3,287,467 $79.9 Million
Q4 2019 Jan 31, 2020	BUY	$20.78 - $29.99 $6.01 Million - $8.67 Million	289,015 Added 10.46%	3,053,251 $85.2 Million
Q3 2019 Oct 31, 2019	BUY	$23.87 - $30.93 $39 Million - $50.5 Million	1,633,287 Added 144.42%	2,764,236 $66.3 Million
Q2 2019 Jul 29, 2019	BUY	$22.1 - $28.56 $11.8 Million - $15.3 Million	534,049 Added 89.47%	1,130,949 $32.2 Million
Q1 2019 May 08, 2019	BUY	$12.0 - $25.76 $7.16 Million - $15.4 Million	596,900 New	596,900 $14.9 Million

Others Institutions Holding VCYT

# of Institutions

295

Shares Held

77.2M

Call Options Held

Put Options Held

17.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.55B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Veracyte, Inc. Transaction History